{"id":"https://openalex.org/W2034341968","doi":"https://doi.org/10.1016/0014-2999(96)00205-1","title":"Treatment with an antisense oligodeoxynucleotide to the GABAA receptor \u03b32 subunit increases convulsive threshold for \u03b2-CCM, a benzodiazepine \u2018inverse agonist\u2019, in rats","display_name":"Treatment with an antisense oligodeoxynucleotide to the GABAA receptor \u03b32 subunit increases convulsive threshold for \u03b2-CCM, a benzodiazepine \u2018inverse agonist\u2019, in rats","publication_year":1996,"publication_date":"1996-06-01","ids":{"openalex":"https://openalex.org/W2034341968","doi":"https://doi.org/10.1016/0014-2999(96)00205-1","mag":"2034341968","pmid":"https://pubmed.ncbi.nlm.nih.gov/8813615"},"language":"en","primary_location":{"id":"doi:10.1016/0014-2999(96)00205-1","doi":"https://doi.org/10.1016/0014-2999(96)00205-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2999(96)00205-1","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007641079","display_name":"Tai-Jun Zhao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tai-jun Zhao","raw_affiliation_strings":["Department of Pharmacology, Medical College of Ohio, Toledo 43699, USA","Dept. of Pharmacology, Medical College of Ohio, Toledo, OH 43699 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Medical College of Ohio, Toledo 43699, USA","institution_ids":[]},{"raw_affiliation_string":"Dept. of Pharmacology, Medical College of Ohio, Toledo, OH 43699 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045289644","display_name":"Howard C. Rosenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I12057038","display_name":"University of Toledo Medical Center","ror":"https://ror.org/01600wh70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I12057038"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Howard C. Rosenberg","raw_affiliation_strings":["Department of Pharmacology, Medical College of Ohio, Toledo, OH 43699, USA","Dept. of Pharmacology, Medical College of Ohio, Toledo, OH 43699 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Medical College of Ohio, Toledo, OH 43699, USA","institution_ids":["https://openalex.org/I12057038"]},{"raw_affiliation_string":"Dept. of Pharmacology, Medical College of Ohio, Toledo, OH 43699 USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110077432","display_name":"Ted H. Chiu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I12057038","display_name":"University of Toledo Medical Center","ror":"https://ror.org/01600wh70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I12057038"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ted H. Chiu","raw_affiliation_strings":["Department of Pharmacology, Medical College of Ohio, Toledo, OH 43699, USA","Dept. of Pharmacology, Medical College of Ohio, Toledo, OH 43699 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Medical College of Ohio, Toledo, OH 43699, USA","institution_ids":["https://openalex.org/I12057038"]},{"raw_affiliation_string":"Dept. of Pharmacology, Medical College of Ohio, Toledo, OH 43699 USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5045289644"],"corresponding_institution_ids":["https://openalex.org/I12057038"],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":null,"fwci":0.7784,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.66348179,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"306","issue":"1-3","first_page":"61","last_page":"66"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9663000106811523,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9663000106811523,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.023399999365210533,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gaba-a-receptor","display_name":"GABAA receptor","score":0.8619999885559082},{"id":"https://openalex.org/keywords/gamma2-subunit","display_name":"gamma2 subunit","score":0.8429999947547913},{"id":"https://openalex.org/keywords/antisense-oligodeoxynucleotides","display_name":"antisense oligodeoxynucleotides","score":0.9739999771118164},{"id":"https://openalex.org/keywords/benzodiazepine-inverse-agonist","display_name":"benzodiazepine inverse agonist","score":0.984000027179718},{"id":"https://openalex.org/keywords/seizure-threshold","display_name":"seizure threshold","score":0.9089999794960022},{"id":"https://openalex.org/keywords/benzodiazepine-receptor","display_name":"benzodiazepine receptor","score":0.8479999899864197},{"id":"https://openalex.org/keywords/phosphorothioate-modification","display_name":"phosphorothioate modification","score":0.8149999976158142},{"id":"https://openalex.org/keywords/intracerebroventricular-injection","display_name":"intracerebroventricular administration","score":0.8629999756813049},{"id":"https://openalex.org/keywords/picrotoxin","display_name":"picrotoxin","score":0.8769999742507935},{"id":"https://openalex.org/keywords/strychnine","display_name":"strychnine","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C89951826","wikidata":"https://www.wikidata.org/wiki/Q1671731","display_name":"Inverse agonist","level":4,"score":0.8504224419593811},{"id":"https://openalex.org/C2779324764","wikidata":"https://www.wikidata.org/wiki/Q416602","display_name":"Picrotoxin","level":4,"score":0.8129891157150269},{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.7875142097473145},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6977392435073853},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.595643937587738},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5843700766563416},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.5193597078323364},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5114940404891968},{"id":"https://openalex.org/C9224880","wikidata":"https://www.wikidata.org/wiki/Q798179","display_name":"GABAA-rho receptor","level":4,"score":0.44002437591552734},{"id":"https://openalex.org/C2778409475","wikidata":"https://www.wikidata.org/wiki/Q421920","display_name":"Flumazenil","level":4,"score":0.428152859210968},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4031282663345337},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3758317530155182},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31280916929244995},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24293118715286255},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23024588823318481}],"mesh":[{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002243","descriptor_name":"Carbolines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002243","descriptor_name":"Carbolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003292","descriptor_name":"Convulsants","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003292","descriptor_name":"Convulsants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007276","descriptor_name":"Injections, Intraventricular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010852","descriptor_name":"Picrotoxin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011897","descriptor_name":"Random Allocation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013331","descriptor_name":"Strychnine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0014-2999(96)00205-1","doi":"https://doi.org/10.1016/0014-2999(96)00205-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2999(96)00205-1","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:8813615","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8813615","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2820294132","display_name":null,"funder_award_id":"DA02194","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G5777813667","display_name":"PHARMACOLOGY OF BENZODIAZEPINE TOLERANCE AND DEPENDENCE","funder_award_id":"R01DA002194","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W249845531","https://openalex.org/W1557959115","https://openalex.org/W1567146715","https://openalex.org/W1804795305","https://openalex.org/W1929455229","https://openalex.org/W1964606034","https://openalex.org/W1964806566","https://openalex.org/W1967166165","https://openalex.org/W1967878409","https://openalex.org/W1968898388","https://openalex.org/W1975347123","https://openalex.org/W1981955447","https://openalex.org/W1983967908","https://openalex.org/W1984519562","https://openalex.org/W1988793221","https://openalex.org/W1991630622","https://openalex.org/W1994261508","https://openalex.org/W1996033662","https://openalex.org/W1996339077","https://openalex.org/W1998624786","https://openalex.org/W2007947877","https://openalex.org/W2014522414","https://openalex.org/W2014957268","https://openalex.org/W2016763640","https://openalex.org/W2025810192","https://openalex.org/W2032218383","https://openalex.org/W2042976056","https://openalex.org/W2051403306","https://openalex.org/W2056945518","https://openalex.org/W2060053228","https://openalex.org/W2067237230","https://openalex.org/W2078223791","https://openalex.org/W2079803201","https://openalex.org/W2081317561","https://openalex.org/W2085783013","https://openalex.org/W2094151893","https://openalex.org/W2133458388","https://openalex.org/W2163815564","https://openalex.org/W2330700346"],"related_works":["https://openalex.org/W2014957268","https://openalex.org/W1902334961","https://openalex.org/W7096701572","https://openalex.org/W2081218281","https://openalex.org/W1980916054","https://openalex.org/W1976709968","https://openalex.org/W2184876102","https://openalex.org/W2012072112","https://openalex.org/W4406056957","https://openalex.org/W1971251591"],"abstract_inverted_index":null,"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}